Neuromod Devices, the medical device company that specialises in tinnitus treatment, has announced they are partnering with four UK clinics to expand the availability of Lenire®, the clinically proven tinnitus treatment device.
Tinnitus, which is commonly known as “ringing in the ears” affects an estimated nine million people in the UK. This latest expansion doubles the number of clinics providing Lenire in the UK to meet the unaddressed demand for tinnitus treatment options. The expansion adds new partnerships with Harley Street Hearing in London, Alto Hearing and Tinnitus in Kenilworth, Durham Hearing Specialists in Durham, and Aberystwyth Hearing in Aberystwyth.
Lenire® is a bimodal neuromodulation device which has been proven to provide long lasting relief from tinnitus across multiple clinical trials. Lenire treats tinnitus through a combination of auditory and tongue stimulation that retrains the brain to significantly reduce tinnitus focus.
FDA approved, Lenire has been proven safe and effective across three large-scale clinical trials that featured over 600 patients.
In Lenire’s most recent clinical trial, TENT-A3, Lenire was shown to be clinically superior to sound-only for the majority of patients with bothersome tinnitus. 91% of patients reported improvement that sustained for a year after Lemire's second clinical trial, TENT-A2, concluded.
Analysis of 220 real world Lenire patients further validated Lenire’s effectiveness as a tinnitus treatment device. The paper showed that 91.5% of patients at Alaska Hearing and Tinnitus had a clinically significant reduction in tinnitus after 12 weeks of treatment with Lenire.
FURTHER INFORMATION:
Lenire is now available through hearing and tinnitus care clinics in the UK. Tinnitus patients can find a nearby clinic and book an appointment by visiting www.lenire.com/find-a-clinic.
